EXPERIMENTAL CHEMOTHERAPY

By W. CAVIL

1 ANTIBODY–DRUG CONJUGATES: A NEW THERAPEUTIC APPROACH FOR TRIPLE-NEGATIVE BREAST CANCER 2 IMMUNE-CHECKPOINT INHIBITORS: A NEW LINE OF ATTACK IN TRIPLE-NEGATIVE BREAST CANCER 3 SCREENING PROGRAMS FOR BREAST CANCER: TOWARD INDIVIDUALIZED, RISK-ADAPTED STRATEGIES OF EARLY DETECTION 4 TRANSVERSAL PERSPECTIVES OF INTEGRATIVE ONCOLOGY CARE IN GASTRIC AND LOBULAR BREAST CANCER 5 ASSESSMENT AND RESPONSE TO NEOADJUVANT TREATMENTS IN BREAST CANCER: CURRENT PRACTICE, RESPONSE MONITORING, FUTURE APPROACHES AND PERSPECTIVES 6 ESTIMATING THE BENEFIT OF PREOPERATIVE SYSTEMIC THERAPY TO REDUCE THE EXTENT OF BREAST CANCER SURGERY: CURRENT STANDARD AND FUTURE DIRECTIONS 7 A PRECISE APPROACH FOR RADIOTHERAPY OF BREAST CANCER 8 FAST MIMICKING DIETS AND OTHER INNOVATIVE NUTRITIONAL INTERVENTIONS TO TREAT PATIENTS WITH BREAST CANCER 9 MECHANISMS OF ENDOCRINE RESISTANCE IN HORMONE RECEPTOR-POSITIVE BREAST CANCER 10 INNOVATIVE THERAPEUTIC APPROACHES FOR PATIENTS WITH HER2-POSITIVE BREAST CANCER 11 BREAST CANCER BRAIN METASTASES: ACHILLES’ HEEL IN BREAST CANCER PATIENTS’ CARE 12 NEW CONCEPTS IN CARDIO-ONCOLOGY 13 NEXT-GENERATION SEQUENCING FOR ADVANCED BREAST CANCER: WHAT THE WAY TO GO? 14 THE GLOBAL LANDSCAPE ON THE ACCESS TO CANCER MEDICINES FOR BREAST CANCER: THE ONCOLLEGE EXPERIENCE